You are here

Article info

Article menu

Download PDFPDF

XML
Addiction
Protocol
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol

Authors

  • Amy Peacock National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia School of Medicine, University of Tasmania, Hobart, Tasmania, Australia PubMed articlesGoogle scholar articles
  • Briony Larance National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Michael Farrell National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Rose Cairns NSW Poisons Information Centre, The Children’s Hospital at Westmead, Sydney, New South Wales, Australia School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Nicholas Buckley NSW Poisons Information Centre, The Children’s Hospital at Westmead, Sydney, New South Wales, Australia School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Louisa Degenhardt National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia Murdoch Children’s Research Institute, Parkville, Victoria, Australia Department of Global Health, School of Public Health, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Amy Peacock; Amy.Peacock{at}unsw.edu.au
View Full Text

Citation

Peacock A, Larance B, Farrell M, et al
Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol
BMJ Open 2018;8:e020006. doi: 10.1136/bmjopen-2017-020006

Publication history

  • Received October 9, 2017
  • Revised February 12, 2018
  • Accepted February 15, 2018
  • First published March 23, 2018.
Online issue publication 
January 10, 2022
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/